Efficacy and safety of ciprofol versus remimazolam combined with alfentanil for sedation during outpatient colonoscopy: a randomized double-blind noninferiority trial
Xuan Liu, Qianqian Tang, Ning Zou, Changming Wang, Xuejun Guo · 2026
Read Efficacy and safety of ciprofol versus remimazolam combined with alfentanil for sedation during outpatient colonoscopy: a randomized double-blind noninferiority trial by Xuan Liu, Qianqian Tang, Ning Zou, Changming Wang, Xuejun Guo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13635916.txt.
Description
Xuan Liu and co-authors compare two sedatives for outpatient colonoscopy in a head-to-head trial. Their 2026 randomized study pits ciprofol against remimazolam, each paired with the same pain drug. Scopes are uncomfortable, sedation is now routine, and newer agents promise smoother work for doctors and patients alike.
One hundred seventy-six patients were split evenly and blinded between the two drugs. The main test was whether the procedure succeeded. Both arms nearly aced it: every ciprofol patient finished, and all but one in the other arm. The gap sat well inside the preset fairness margin, so the newer drug counts as non-inferior. Wake and discharge times, patient and doctor satisfaction, and side effects filled out the scorecard. The authors offer the result as cover for choosing either agent.
Catalog record
| CREATOR | Xuan Liu, Qianqian Tang, Ning Zou, Changming Wang, Xuejun Guo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |